Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients

2014 ◽  
Vol 29 (1) ◽  
pp. 42-47 ◽  
Author(s):  
J.S. Hong ◽  
H.H. Kwon ◽  
S.Y. Park ◽  
J.Y. Jung ◽  
J.Y. Yoon ◽  
...  
Author(s):  
Cenk Yasa ◽  
Özlem Dural ◽  
Ercan Bastu ◽  
Funda Güngör Uğurlucan

<p>PPolycystic ovary syndrome is the most common endocrine abnormality that affects reproductive-aged women. Diagnostic criteria of polycystic ovary syndrome have been established by different societies in recent years, and hyperandrogenism remains as one of the main criteria for diagnosis. Cutaneous manifestations of hyperandrogenism include hirsutism, acne and androgenic alopecia and are commonly observed in women with polycystic ovary syndrome. The major determinants of cutaneous manifestations are increased production of androgen and increased tissue availability. Cutaneous manifestations of hyperandrogenism are cosmetic problems, which produce significant emotional distress and psychological morbidity. Treatment includes a combination of combined oral contraceptives, antiandrogens, insulin sensitizers, gonadotropin releasing hormone agonists, topical medications, and cosmetic procedures. The diagnosis, management, and treatment approaches are described in detail in this review.</p>


Cureus ◽  
2021 ◽  
Author(s):  
Yara E Aljefri ◽  
Rana A Alahmadi ◽  
Rakan S Alajmi ◽  
Taif A Alkhamisi ◽  
Hadeel A Maaddawi ◽  
...  

2021 ◽  
Vol 13 (2) ◽  
Author(s):  
Mohammad A. Abusailik ◽  
Alsharif M. Muhanna ◽  
Adam A. Almuhisen ◽  
Abdullah M. Alhasanat ◽  
Ayed M. Alshamaseen ◽  
...  

The aim of this cross-sectional study, that included 146 polycystic ovary syndrome (PCOS) patients, was to evaluate the prevalence, severity and pattern of cutaneous manifestation in Jordanian women with PCOS, as well as their correlation with hormonal abnormalities. A thorough complete cutaneous examination, hormonal assays (Luteinizing hormone [LH], follicle stimulating hormone [FSH], prolactin, total testosterone, free testosterone, dehydroepiandrosterone sulfate) and pelvic ultrasonography were done. The most common cutaneous features of PCOS were acne vulgaris (75.3%) followed by hirsutism (59.6%) then seborrhea (43.2%) and androgenetic alopecia (42.5%). Patients who had acne vulgaris presented at a younger age than patients who did not. Patients who had androgenetic alopecia and stria were older than patients with no such features. Moreover, all cutaneous manifestations of PCOS, except for acne, were associated with higher body mass index (BMI). Elevated LH:FSH ratio of more than 2:1 was the most common hormonal abnormality, followed by increased LH and total testosterone. Acne, hirsutism, androgenetic alopecia, seborrhea, acanthosis nigricans and skin tags are common cutaneous manifestations among Jordanian patients with PCOS. The existence of one or more of these features, especially in overweight and obese patients, should alert the physician towards the possibility of having PCOS.


Sign in / Sign up

Export Citation Format

Share Document